1. Home
  2. DTSQ vs HLVX Comparison

DTSQ vs HLVX Comparison

Compare DTSQ & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTSQ
  • HLVX
  • Stock Information
  • Founded
  • DTSQ 2022
  • HLVX 2020
  • Country
  • DTSQ United States
  • HLVX United States
  • Employees
  • DTSQ N/A
  • HLVX N/A
  • Industry
  • DTSQ
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTSQ
  • HLVX Health Care
  • Exchange
  • DTSQ NYSE
  • HLVX Nasdaq
  • Market Cap
  • DTSQ 91.7M
  • HLVX 83.7M
  • IPO Year
  • DTSQ 2024
  • HLVX 2022
  • Fundamental
  • Price
  • DTSQ N/A
  • HLVX $2.06
  • Analyst Decision
  • DTSQ
  • HLVX Hold
  • Analyst Count
  • DTSQ 0
  • HLVX 5
  • Target Price
  • DTSQ N/A
  • HLVX $2.33
  • AVG Volume (30 Days)
  • DTSQ 353.0
  • HLVX 454.3K
  • Earning Date
  • DTSQ 01-01-0001
  • HLVX 08-07-2025
  • Dividend Yield
  • DTSQ N/A
  • HLVX N/A
  • EPS Growth
  • DTSQ N/A
  • HLVX N/A
  • EPS
  • DTSQ 0.28
  • HLVX N/A
  • Revenue
  • DTSQ N/A
  • HLVX N/A
  • Revenue This Year
  • DTSQ N/A
  • HLVX N/A
  • Revenue Next Year
  • DTSQ N/A
  • HLVX N/A
  • P/E Ratio
  • DTSQ $37.05
  • HLVX N/A
  • Revenue Growth
  • DTSQ N/A
  • HLVX N/A
  • 52 Week Low
  • DTSQ $9.96
  • HLVX $1.34
  • 52 Week High
  • DTSQ $10.47
  • HLVX $14.43
  • Technical
  • Relative Strength Index (RSI)
  • DTSQ N/A
  • HLVX 63.20
  • Support Level
  • DTSQ N/A
  • HLVX $1.99
  • Resistance Level
  • DTSQ N/A
  • HLVX $2.12
  • Average True Range (ATR)
  • DTSQ 0.00
  • HLVX 0.08
  • MACD
  • DTSQ 0.00
  • HLVX 0.02
  • Stochastic Oscillator
  • DTSQ 0.00
  • HLVX 80.33

About DTSQ DT CLOUD STAR ACQUISITION CORP

DT Cloud Star Acquisition Corp is a blank check company.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: